Comprehensive Study of the Global Diabetes Market (2018-2024) Featuring Profiles of Key Players Abbott Labs, BD & Co, Eli Lilly & Co, GSK, NextCell Pharma, and More

News provided by

Feb 26, 2020, 08:30 ET

DUBLIN, Feb. 26, 2020 /PRNewswire/ -- The "Latest Development, Product Innovations and Treatments for Diabetes" report has been added to ResearchAndMarkets.com's offering.

This report includes:

An overview of the global market for diabetes treatment and discussion on the latest developments and product innovations in the industry
Analyses of global market trends, with data from 2018, 2019, and projections of compound annual growth rates (CAGRs) through 2024
Coverage of diabetes background, its prevalence and its threat to world health
Briefing about blood glucose monitoring and diagnostic systems and devices
Discussion on top drug treatments and their latest breakthroughs
Information on the artificial, or Bionic pancreas
A look at the measures taken to confront diabetes at the local, regional, national and trans-national level by raising awareness in parliaments and assemblies across the world
Evaluation of current market size, market forecast, and market share analysis of the leading suppliers of the industry
Insights into individual country policies and strategies to combat diabetes
Comprehensive company profiles of key players in the market, including Abbott Laboratories, Becton, Dickinson and Co., Eli Lilly and Co., GlaxoSmithKline PLC and NextCell Pharma AB

The key objectives of the study are to:

Review the impact that diabetes is having on global health. This includes:

Review of diabetes as a disease.
Review of the epidemiology of diabetes.
Data and statistics by region.
Predictions of future incidence and prevalence of diabetes globally and by region.
Review of the impact that diabetes has and will have in the future.
Review of the current products available within the following individual product segment and subsegments.

Blood glucose monitoring and diagnostic systems and devices.
Insulin-delivery devices.
Antidiabetic medications.

Review the latest technological advances and developments in blood glucose monitoring and diagnostic systems and devices. This includes:

Flash glucose monitoring (FGM).
New and novel approaches to blood glucose monitoring.
Review of the latest developments in continuous glucose monitoring (CGM) systems.

Review the latest technological advances and developments in insulin-delivery devices. This includes:

Insulin syringes.
Insulin pens and needles (reusable and disposable).
Insulin jet injectors.
External insulin pumps.
Implantable insulin pumps.
Insulin inhalers.
Insulin patches.

Review the latest technological advances and pipeline developments in Antidiabetic medications. This includes:

Review of the classification of Antidiabetic medications under the titles of injectable Antidiabetic medications and oral Antidiabetic drugs (OADS).
Review of the current product pipeline for new and innovative Antidiabetic medications.
Review the range of joint ventures, collaborations, licenses and research agreements currently focused on new medical device technologies.
Review of the regulatory requirements, intellectual property protection and concerns, patents and trademark process.
Review of the impact that the new and improved technologies will have on market dynamics by geographic region.
Survey of the key players involved in the development of new and innovative medical device technologies and Antidiabetic medications together with major improvements to existing technologies, as well as company profiles.

By purchasing this study, the reader will gain:

An improved understanding of the current state, future developments and latest product innovations in both medical devices and medications used to treat diabetes.
The latest information on the leading companies engaged in developing new and improving existing medical devices and medications, a review of the status of their product pipelines and insight into their proprietary technologies.
An understanding of the impact that these new products and technologies will have on the growth and development of the medical market.
An appreciation of how these new medical devices and medications will affect the provision of healthcare, how they will provide clinicians with new methods to treat existing conditions and how these technologies will improve clinical outcomes for patients.
An appreciation of the market restraints and drivers influencing the growth and development of this market.
The impact that diabetes has on the population and the implications as a global pandemic.

The analysis includes the use of charts and graphs measuring product growth and trends within the marketplace. Company-specific information, including sales figures, product pipeline status and R&D trends, are provided throughout the report.

Key Topics Covered

Chapter 1 Introduction

Introduction
Diabetes
Type 1 Diabetes
Type 2 Diabetes
Scope of Report
Methodology and Information Sources
Primary Data and Information Gathering
Secondary Data and Information Gathering
Market Revenue Forecasts

Chapter 2 Summary and Highlights

Global Market for Diabetes Treatments
Regional Overview
Market Segmentation
Major Developments and Trends in Innovative Diabetes Treatment Technologies
Blood Glucose Monitoring and Diagnostic Systems and Devices
Insulin Delivery Devices
Diabetic Medications

Chapter 3 Introduction to Diabetes and Its Threat to World Health

Introduction to Diabetes
What is Diabetes?
Types of Diabetes
Type 1 Diabetes
Type 2 Diabetes
Gestational Diabetes Mellitus (GDM) or Hyperglycemia in Pregnancy
Impaired Glucose Tolerance (IGT) and Impaired Fasting Glucose (IFG)
Epidemiology of Diabetes
Gender Distribution
Regional Disparities
Data and Statistics by Region
Key Facts and Latest Data: North America and the Caribbean Region
Key Facts and Latest Data: Europe
Key Facts and Latest Data: South and Central America
Key Facts and Latest Data: Southeast Asia
Key Facts and Latest Data: Western Pacific
Key Facts and Latest Data: The Middle East and North Africa
Key Facts and Latest Data: Africa
Top 10 Countries/Territories for Number of People Aged 20-79 with Diabetes
Undiagnosed Diabetes
Healthcare Expenditure Associated with Diabetes

Chapter 4 Blood Glucose Monitoring and Diagnostic Systems and Devices

Introduction to Blood Glucose Monitoring and Diagnostic Systems and Devices
Self-Monitoring of Blood Glucose (SMBG)
SMBG Market Structure
Latest Technological Advances and Developments in Blood Glucose Devices
Continuous Glucose Monitoring (CGM) Systems
History and Development of CGM Systems

Chapter 5 Insulin Delivery Devices

Introduction to Insulin Delivery Devices
Insulin Syringes
Advantages of Using Insulin Syringes
Disadvantages of Using Insulin Syringes
Latest Technological Advances and Developments in Insulin Syringes
Insulin Delivery Pen Devices
Disposable Insulin Pens
Reusable Insulin Pens
Latest Technological Advances and Developments in Insulin Delivery Pen Devices
Insulin Jet Injectors
Advantages of Using Insulin Jet injectors
Disadvantages of Using Insulin Jet injectors
External Insulin Pumps
Advantages of Insulin Pumps
Disadvantages of Insulin Pumps
Latest Technological Advances and Developments in Insulin Pump Systems
Implantable Insulin Pumps
Closed-Loop Artificial Pancreas
Bionic Pancreas
The Artificial Pancreas (the Physiological Approach)
Insulin Inhalers
Advantages of Insulin Inhalers
Disadvantages of Insulin Inhalers
Types of Insulin Inhalers
Insulin Patches
Prometheon Pharma
CeQur SA
EOFlow
Zenomics Inc.
Oral Insulin Delivery
Novo Nordisk and NIH Funds Research at MIT
Oramed Pharmaceuticals
Diabetology Ltd.

Chapter 6 Antidiabetic Medications

Introduction
Classification and Types of Antidiabetic Medications
Injectable Therapies for Diabetes
Oral Antidiabetic Drugs (OADs)
Facing the Patent Cliff
Latest Technological Advances, Developments and Product Pipelines for Diabetic Medications
Current Product Pipeline
Other Potential Therapies Currently Under Investigation

Chapter 7 Regional Markets for Diabetes Treatments

Introduction
Global Market for Diabetes Treatments
Regional Overview
North American Market for Diabetes Treatments
European Market for Diabetes Treatments
Asia-Pacific Market for Diabetes Treatments
Latin American Market for Diabetes Treatments
Middle Eastern and African Market for Diabetes Treatments
Market Factors Driving the Growth and Development of the Diabetic Pharmaceutical Market
Market Drivers
Market Restraints

Chapter 8 Global Market for Glucose Monitoring and Diagnostic Products

Introduction
Global Glucose Monitoring and Diagnostic Product Market
Overview of the Regional Markets
Glucose Monitoring and Diagnostic Product Market by Region
North America
Europe
Asia-Pacific
Latin America
Middle East and Africa
Global Market Share Analysis
Glucose Monitoring and Diagnostic Products
Blood Glucose Test Strips, Glucose Meters, Lancets and Lancet Devices
Continuous Glucose Monitoring Products

Chapter 9 Global Market for Insulin Delivery Products and Devices

Introduction
Global Insulin Delivery Products and Devices Market
Overview of the Regional Markets
Insulin Delivery Products and Device Market by Region
North America
Europe
Asia-Pacific
Latin America
Middle East and Africa
Market Share Analysis

Chapter 10 Global Market for Antidiabetic Pharmaceuticals

Introduction
Global Antidiabetic Pharmaceutical Market
Overview of the Regional Markets
Antidiabetic Pharmaceuticals Market by Region
North America
Europe
Asia-Pacific
Latin America
Middle East and Africa
Market Share Analysis

Chapter 11 Company Profiles

Introduction
Tier 1 Major Multinational Medical Device Corporations
Abbott Laboratories
Ascensia Diabetes Care Holdings Ag
Astrazeneca Plc
Bayer Ag
Becton, Dickinson And Co.
Beckman Coulter (Part Of Danaher)
Boston Scientific Corp.
B. Braun Melsungen Ag
Eli Lilly And Co.
Glaxosmithkline Plc
Insulet Corp.
Johnson & Johnson
Lifescan Inc.
Medtronic Inc.
Novo Nordisk A/S
Pfizer Inc.
Roche (Formerly Hoffmann-La Roche Ltd.)
Sanofi S.A.
Terumo Corp.
Tier 2 Entrepreneurial Small And Medium-Sized Enterprises
Agamatrix Inc.
Altucell Inc.
Beta-O2 Technologies
Betalin Therapeutics
Dariohealth Corp.
Dexcom Inc.
Evotec Se
Lexicon Pharmaceuticals Inc.
Mesoblast Ltd.
Nextcell Pharma Ab
Orgenesis Inc.
Osiris Therapeutics Inc. (Subsidiary Of Smith & Nephew Plc)
Senseonics Holdings Inc.
Sernova Corp.
Seraxis Inc.
Tandem Diabetes Care, Inc.
Valeritas Holdings Inc.
Viacyte Inc.
VTV Therapeutics Inc.
Unicyte Ag
Ypsomed Holding Ag

For more information about this report visit https://www.researchandmarkets.com/r/t6d7k6

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets